Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinya Sato

Showing results (451-460 of 514) with videos related to

Pageof 52
Sort By:
Cancer Research|May 31, 2013
Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastomaAtsushi Natsume, Motokazu Ito, Keisuke Katsushima, et al.
Internal Medicine (Tokyo, Japan)|December 26, 2019
Secondary Pulmonary Alveolar Proteinosis Following Treatment with Azacitidine for Myelodysplastic SyndromeMiki Hashimoto, Hidehiro Itonaga, Yasuhito Nannya, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 29, 2016
Combined treatment with dipeptidyl peptidase-4 inhibitor (sitagliptin) and angiotensin-II type 1 receptor blocker (losartan) suppresses progression in a non-diabetic rat model of steatohepatitisYasushi Okura, Tadashi Namisaki, Kei Moriya, et al.
Scientific Reports|June 12, 2020
Genome-enabled phylogenetic and functional reconstruction of an araphid pennate diatom Plagiostriata sp. CCMP470, previously assigned as a radial centric diatom, and its bacterial commensalShinya Sato, Deepak Nanjappa, Richard G Dorrell, et al.
BMC Gastroenterology|January 21, 2018
Treatment of long-segment Barrett's adenocarcinoma by complete circular endoscopic submucosal dissection: a case reportMiki Kaneko, Akira Mitoro, Motoyuki Yoshida, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 3, 2025
Prognostic significance of skeletal muscle mass in patients with alcohol-related cirrhosisAkihiko Shibamoto, Tadashi Namisaki, Satoshi Iwai, et al.
Blood Advances|June 18, 2026
Treatment-Free Remission and Immune Profiling after Frontline Second-Generation TKI Therapy in CMLNaoto Takahashi, Yosuke Minami, Yuki Fujioka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 27, 2018
Combining probiotics and an angiotensin-II type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of non-alcoholic steatohepatitisYasuhiko Sawada, Hideto Kawaratani, Takuya Kubo, et al.
Molecular Therapy. Nucleic Acids|March 3, 2025
<i>In vivo</i> production of engineered ACE2 decoy protects lungs from SARS-CoV-2 infectionYuta Suzuki, Takayuki Miyazaki, Yoko Ida, et al.
International Journal of Molecular Sciences|April 5, 2020
Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of SteatohepatitisTakahiro Ozutsumi, Tadashi Namisaki, Naotaka Shimozato, et al.
Pageof 52

Showing results (451-460 of 514) with videos related to

Sort By:
Pageof 52
Cancer Research|May 31, 2013
Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastomaAtsushi Natsume, Motokazu Ito, Keisuke Katsushima, et al.
Internal Medicine (Tokyo, Japan)|December 26, 2019
Secondary Pulmonary Alveolar Proteinosis Following Treatment with Azacitidine for Myelodysplastic SyndromeMiki Hashimoto, Hidehiro Itonaga, Yasuhito Nannya, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 29, 2016
Combined treatment with dipeptidyl peptidase-4 inhibitor (sitagliptin) and angiotensin-II type 1 receptor blocker (losartan) suppresses progression in a non-diabetic rat model of steatohepatitisYasushi Okura, Tadashi Namisaki, Kei Moriya, et al.
Scientific Reports|June 12, 2020
Genome-enabled phylogenetic and functional reconstruction of an araphid pennate diatom Plagiostriata sp. CCMP470, previously assigned as a radial centric diatom, and its bacterial commensalShinya Sato, Deepak Nanjappa, Richard G Dorrell, et al.
BMC Gastroenterology|January 21, 2018
Treatment of long-segment Barrett's adenocarcinoma by complete circular endoscopic submucosal dissection: a case reportMiki Kaneko, Akira Mitoro, Motoyuki Yoshida, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 3, 2025
Prognostic significance of skeletal muscle mass in patients with alcohol-related cirrhosisAkihiko Shibamoto, Tadashi Namisaki, Satoshi Iwai, et al.
Blood Advances|June 18, 2026
Treatment-Free Remission and Immune Profiling after Frontline Second-Generation TKI Therapy in CMLNaoto Takahashi, Yosuke Minami, Yuki Fujioka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 27, 2018
Combining probiotics and an angiotensin-II type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of non-alcoholic steatohepatitisYasuhiko Sawada, Hideto Kawaratani, Takuya Kubo, et al.
Molecular Therapy. Nucleic Acids|March 3, 2025
<i>In vivo</i> production of engineered ACE2 decoy protects lungs from SARS-CoV-2 infectionYuta Suzuki, Takayuki Miyazaki, Yoko Ida, et al.
International Journal of Molecular Sciences|April 5, 2020
Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of SteatohepatitisTakahiro Ozutsumi, Tadashi Namisaki, Naotaka Shimozato, et al.
Pageof 52